Indus Towers Limited Subsidiary Incorporated in GIFT City
Indus Towers Limited has successfully incorporated a new wholly owned subsidiary, Indus Towers Global Ventures IFSC Limited, in the Gujarat…
Star Health and Allied Insurance FY26 Earnings Highlight Robust Growth and Profitability
Star Health and Allied Insurance reports a strong performance for FY26, marked by a 16% year-on-year growth in Gross Written Premium (GWP),…
KPIT Technologies Board Approves Grant of 21,000 Restricted Stock Units
KPIT Technologies has announced the grant of 21,000 options to eligible employees under its Restricted Stock Unit (RSU) Plan 2022. Approved by…
Firstsource Solutions Executive Vice President Jagriti Bhattacharyya Resigns
Firstsource Solutions Limited has announced that Jagriti Bhattacharyya, the company’s Executive Vice President, General Counsel, and Senior…
Reliance Power Limited Expiry of Outstanding Warrants
Reliance Power Limited has announced the lapse of 21.82 crore outstanding warrants. These warrants, which were subject to an 18-month…
Maruti Suzuki India Limited Audio Recording of Annual Financial Results Call Released
Maruti Suzuki India Limited has released the audio recording of its investor conference call held on April 28, 2026. The session focused on…
Five-Star Business Finance Limited Board Approves Amendments to Code of Fair Disclosure
Five-Star Business Finance Limited has officially updated its Code of Fair Disclosure. The decision was formalized during a meeting of the…
Piramal Pharma Limited Board Approves FY26 Audited Results and Key Leadership Appointments
Piramal Pharma Limited has announced its audited financial results for the quarter and financial year ended March 31, 2026. Alongside strong…
Piramal Pharma Limited Fiscal Year 2026 Financial Results and Leadership Appointments
Piramal Pharma Limited has reported its audited financial results for the year ended March 31, 2026. The company has announced the…
Piramal Pharma Limited Fiscal Year 2026 Financial Results and Leadership Appointments
Piramal Pharma Limited announced its financial results for the year ended March 31, 2026. The company reported standalone revenue of ₹4,782.01…